ArticleBMC cancer2026

Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCC.

Bernd Uhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.